- Home
- BANC vs RCKT Comparison
BANC vs RCKT Comparison
Compare BANC & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BANC | RCKT |
|---|---|---|
| Founded | 1941 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 340.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BANC | RCKT |
|---|---|---|
| Price | $19.88 | $3.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 14 |
| Target Price | $19.28 | ★ $29.12 |
| AVG Volume (30 Days) | 2.1M | ★ 2.3M |
| Earning Date | 01-22-2026 | 11-06-2025 |
| Dividend Yield | ★ 2.02% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.03 | N/A |
| Revenue | ★ $1,019,965,000.00 | N/A |
| Revenue This Year | $4.33 | N/A |
| Revenue Next Year | $14.27 | N/A |
| P/E Ratio | $19.28 | ★ N/A |
| Revenue Growth | ★ 147.22 | N/A |
| 52 Week Low | $11.52 | $2.19 |
| 52 Week High | $20.17 | $13.50 |
Technical Indicators
Market Signals| Indicator | BANC | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 73.65 | 52.07 |
| Support Level | $19.03 | $3.30 |
| Resistance Level | $20.17 | $3.65 |
| Average True Range (ATR) | 0.41 | 0.19 |
| MACD | 0.13 | 0.05 |
| Stochastic Oscillator | 87.21 | 66.22 |
Price Performance
Historical ComparisonAbout BANC Banc of California Inc.
Banc of California Inc is a financial holding company. It offers banking and financial services. Its services include banking services, lending services, and private banking services. Its deposit and banking product and service offerings include checking, savings, money market, certificates of deposit, and retirement accounts. Lending activities are focused on providing financing to California's diverse private businesses, entrepreneurs, and communities, and loans are often secured by California commercial and residential real estate. The company has one reportable segment named Commercial banking.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.